Enliven Therapeutics Inc (ELVN) Stock Price

22.07 ▲ +1.80 (+8.88%)
Open: 19.88 Vol: 565.73K Day's range: 19.84 - 22.32 Nov 14, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ELVN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 22.09▼ 22.08▼ 22.01▲ 20.20▲ 21.03▲
MA10 22.14▼ 22.00▲ 21.39▲ 19.44▲ 20.45▲
MA20 22.09▼ 21.29▲ 20.91▲ 20.62▲ 20.47▲
MA50 22.00▲ 20.57▲ 19.43▲ 20.23▲ 20.58▲
MA100 21.34▲ 19.35▲ 20.39▲ 20.33▲ 20.80▲
MA200 20.89▲ 20.43▲ 20.71▲ 20.06▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.023▼ 0.043▲ 0.110▲ 0.050▲ 0.144▲
RSI 49.999▼ 69.369▲ 70.466▲ 58.236▲ 53.709▲
STOCH 35.604     90.597▲ 94.091▲ 44.098     61.810    
WILL %R -57.895     -9.649▲ -9.302▲ -32.781     -32.781    
CCI -175.183▼ 61.736     90.648     44.919     34.314    
Latest Filters Detected On ELVN
▲ RSI&MACD $ELVN MACD cross and RSI above 55 Set Alert
▲ MACD $ELVN MACD(12,26,9) Crossed Above Signal Line Set Alert
MA $ELVN Price Crossed Above MA(26) Set Alert
MA $ELVN Price Crossed Above MA(13) Set Alert
CDL $ELVN Engulfing Candlestick Pattern Detected Set Alert
Enliven Therapeutics Inc News
Enliven Therapeutics, Inc.: Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update
Thursday, November 13, 2025 01:54 AM
Completed enrollment of the randomized Phase 1b cohorts of the ongoing ENABLE trial of ELVN-001 in CML Remains on track to initiate Phase 3 pivotal trial of ELVN-001 ...
Enliven Therapeutics Announces Clinical Data in CML Patients with Atypical Fusion Transcripts at ASH 2025 Annual Meeting
Monday, November 03, 2025 06:23 AM
Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced ...
Enliven Therapeutics Inc.
Saturday, October 18, 2025 06:51 AM
Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of small molecule therapeutics. Its pipeline includes BCR-ABL Program: ...
ELVN historical stock data
date open high low close volume
14/11/25 19.88 22.32 19.84 22.07 565,729
13/11/25 20.31 21.5699 19.935 20.27 459,693
12/11/25 20.00 20.62 19.63 20.30 424,924
11/11/25 18.775 19.71 18.62 19.64 485,361
10/11/25 17.82 18.955 17.82 18.71 575,752
07/11/25 18.40 18.40 16.80 17.63 578,149
06/11/25 18.34 18.56 17.81 18.30 523,622
05/11/25 19.00 19.109 17.77 18.50 264,759
04/11/25 19.34 20.23 18.61 19.01 1,004,025
03/11/25 23.25 23.31 18.33 20.00 2,704,965
Quote Details
52wk Low:13.30
52wk High:26.48
Vol:565.73K
Avg Vol(3m):10M
1Y Chng:-9.66%
1M Chng:+8.72%
Add to Watch List
More Information
Index US Composite
Market Cap. 1.20B